Clinical intervention protocol supporting one-carbon metabolism and methylation cycle function through targeted supplementation of active methyl donors, cofactors, and alternative pathway substrates. Used in cPNI to address epigenetic dysregulation, viral gene reactivation (EBV, SARS-CoV-2), neurotransmitter synthesis deficits, detoxification impairment, and homocysteine elevation. Bypasses genetic polymorphisms (MTHFR, MTR, MTRR, BHMT) by providing pre-methylated forms that do not require enzymatic conversion.
Think of methylation as a factory assembly line that stamps "methyl tags" onto thousands of products per minute—DNA switches, neurotransmitter precursors, detox molecules, and viral gene silencers. Each methyl tag is a three-carbon cluster (CH₃) that gets transferred from donor to target. The factory has two production lines: the "folate line" (MTHFR → 5-MTHF → methionine synthase → SAMe) and the "betaine shortcut line" (BHMT → SAMe directly). Many people have slow or broken machinery on the folate line due to genetic variants—they can't convert folic acid into the active 5-MTHF form. The methylation protocol is like bypassing the broken conveyor belts by delivering pre-assembled methyl tags directly to the factory floor: active 5-MTHF (already folded), methylcobalamin B12 (already activated), and SAMe (the final methyl donor). You also provide the machinery oil (cofactors: B6, B2, zinc, magnesium) and alternative raw materials (betaine for the shortcut line, melatonin which donates 3 methyl groups per molecule). But here's the critical detail: some workers (COMT enzyme) remove methyl tags from neurotransmitters. If COMT is slow (genetic variant), methyl tags accumulate like backed-up inventory—the patient gets anxious, wired, can't sleep. If COMT is fast, methyl tags are burned through quickly and the patient needs higher doses. The protocol must match the factory's removal rate to its supply rate.
The methylation cycle operates through two interconnected pathways that converge at S-adenosylmethionine (SAMe), the universal methyl donor:
Primary Folate-Dependent Pathway:
- Dietary folic acid (synthetic) → dihydrofolate reductase (DHFR) → tetrahydrofolate (THF) → MTHFR enzyme converts to 5-MTHF (active folate)
- 5-MTHF + homocysteine → methionine synthase (MTR, requires methylcobalamin B12 as cofactor) → methionine
- Methionine + ATP → methionine adenosyltransferase (MAT) → SAMe
- SAMe donates methyl group (CH₃) to DNA methyltransferases (DNMT1), histone methyltransferases (KDM5A, KDM6A), COMT, phosphatidylethanolamine N-methyltransferase (PEMT), others
- SAMe (post-donation) → S-adenosylhomocysteine (SAH)
- SAH → SAH hydrolase → homocysteine (cycle resets)
Alternative Betaine-Dependent Pathway:
- Choline → betaine aldehyde dehydrogenase → betaine
- Betaine + homocysteine → BHMT enzyme (requires zinc) → methionine (bypasses folate pathway entirely)
- Methionine → MAT → SAMe (converges with primary pathway)
Cofactor Requirements:
- Vitamin B6 (P5P form) required for: cystathionine β-synthase (CBS, converts homocysteine → cysteine when methylation not needed), serine hydroxymethyltransferase (SHMT2)
- Vitamin B2 (riboflavin) required for: MTHFR enzyme function
- Zinc required for: BHMT enzyme, alcohol dehydrogenase (ADH), carbonic anhydrase
- Magnesium required for: MAT enzyme, methyltransferases (cofactor for ATP-dependent reactions)
Methylation Protocol Intervention Points:
graph TD
A[Dietary Folic Acid] -->|DHFR| B[THF]
B -->|MTHFR slow| C[5-MTHF]
C -->|"MTR + B12"| D[Methionine]
E[Choline] -->|Oxidation| F[Betaine]
F -->|"BHMT + Zn"| D
D -->|"MAT + Mg"| G[SAMe]
G -->|Methylation| H[SAH]
H -->|SAH hydrolase| I[Homocysteine]
I --> C
I --> F
I -->|"CBS + B6"| J["Cysteine → Glutathione"]
K["Protocol: 5-MTHF 1-5mg"] -.->|Bypass MTHFR| C
L["Protocol: Methylcobalamin 1000-5000mcg"] -.->|Activate MTR| C
M["Protocol: SAMe 400-800mg"] -.->|Direct donor| G
N["Protocol: Betaine 500-2000mg"] -.->|Alternative pathway| F
O["Protocol: B6 P5P 50-100mg"] -.->|Cofactor| J
P["Protocol: B2 25-50mg"] -.->|Cofactor| B
Q["Protocol: Melatonin 3-10mg"] -.->|3 methyl groups/molecule| G
G -->|COMT fast variant| R[High methylation demand]
G -->|COMT slow variant| S[Low methylation demand]
Clinical Biochemistry:
- SAMe:SAH ratio >4:1 optimal for methylation reactions; <2:1 indicates functional methylation block
- SAH accumulation inhibits all methyltransferases (competitive inhibitor), creating functional "COMT slowness" even if genotype is fast
- DNA Methylation targets: CpG islands in viral gene promoters (EBV BZLF1, SARS-CoV-2 ORF sequences), inflammatory gene silencing (IL-6, TNF-α promoters), estrogen receptor methylation
- Neurotransmitter synthesis: SAMe required for dopamine → epinephrine (via PNMT), serotonin degradation (via COMT), phosphatidylcholine synthesis (acetylcholine precursor)
- Detoxification: SAMe required for phase II conjugation (glutathione synthesis via transsulfuration, sulfation pathways, glycine conjugation)
This protocol addresses Metamodel 5 (epigenetic reprogramming) and Metamodel 3 (immune-metabolic flexibility) dysfunction at the biochemical root. It is essential for patients presenting with:
Primary Indications:
COMT Genotype Stratification (Critical):
- COMT Val/Val (fast COMT): High methylation demand—burns through methyl groups rapidly degrading catecholamines. Tolerates high-dose protocol: 5-MTHF 5mg, methylcobalamin 5000mcg, SAMe 800mg. Risk: undermethylation symptoms (fatigue, low dopamine, poor focus).
- COMT Met/Met (slow COMT): Low methylation demand—methyl groups accumulate. Start low-dose: 5-MTHF 400-800mcg, methylcobalamin 1000mcg, avoid SAMe initially. Risk: overmethylation syndrome (anxiety, insomnia, palpitations, irritability, histamine release).
- COMT Val/Met (heterozygous): Intermediate. Start mid-dose: 5-MTHF 1-2mg, methylcobalamin 2000mcg, titrate based on response.
Intervention Strategy:
- Assess baseline: Homocysteine, methylmalonic acid (B12 status), whole blood histamine, genetic testing (MTHFR C677T/A1298C, COMT V158M, MTR A2756G, MTRR A66G)
- Start conservative (especially slow COMT): 5-MTHF 400mcg + methylcobalamin 1000mcg + B-complex + magnesium 400mg
- Monitor symptoms weekly: Overmethylation → reduce dose, add niacin 50-100mg (methyl sink). Undermethylation → increase dose, add SAMe or betaine.
- Target endpoints: Homocysteine <7 µmol/L, symptom resolution (energy, mood, viral suppression), inflammatory marker reduction (hs-CRP <1.0 mg/L)
- Avoid: Synthetic folic acid (blocks DHFR, competes with 5-MTHF at folate receptors), high-dose niacin without monitoring (depletes methyl groups excessively)
Evolutionary Context:
Modern diet provides synthetic folic acid (fortified grains) that 40-60% of population cannot efficiently convert due to MTHFR polymorphisms—these variants were neutral or advantageous in ancestral environments with natural folate (leafy greens) but create mismatch disease with processed foods. Methylation protocol restores ancestral biochemistry by providing bioavailable forms.
- Core formula: 5-MTHF 1-5mg + methylcobalamin 1000-5000mcg sublingual/IM + B6 (P5P) 50-100mg + B2 25-50mg + zinc 15-30mg + magnesium 400-600mg
- SAMe dosing: 400-800mg for severe methylation deficiency; take on empty stomach, morning (can be stimulating)
- Betaine dosing: 500-2000mg (trimethylglycine/TMG) as alternative remethylation pathway, especially if BHMT variants present
- Melatonin contribution: Each melatonin molecule donates 3 methyl groups when metabolized; dose 3-10mg supports methylation beyond sleep regulation
- COMT stratification: Slow COMT (Met/Met) = start 5-MTHF 400-800mcg, fast COMT (Val/Val) = tolerate 5mg+ doses
- Homocysteine target: <7 µmol/L optimal (cardiovascular protection, cognitive function); >10 µmol/L indicates intervention needed, >15 µmol/L significant risk
- SAMe:SAH ratio: >4:1 optimal for methyltransferase activity; measure via specialty labs (Doctor's Data, Genova)
- Overmethylation rescue: Niacin (nicotinic acid) 50-100mg acts as methyl sink (converts to nicotinamide via methylation), flush response indicates dosing
- B12 form matters: Methylcobalamin (not cyanocobalamin) required for methionine synthase; sublingual or IM bypass gut absorption issues
- Avoid folic acid: Synthetic form blocks dihydrofolate reductase, competes with 5-MTHF, accumulates as unmetabolized folic acid (UMFA) linked to immune dysfunction
- Transsulfuration pathway: If homocysteine >15 µmol/L despite protocol, add B6 (P5P) 100mg + NAC 600mg to shunt excess homocysteine → cysteine → glutathione
- Choline sources: Eggs (phosphatidylcholine), liver, fish provide betaine precursors; supplemental choline bitartrate 500-1000mg if betaine pathway needed
- DNA Methylation — protocol restores CpG island methylation patterns silencing viral and inflammatory genes
- DNMT1 — SAMe serves as methyl donor substrate for DNA methyltransferase 1 maintaining methylation during replication
- 5-MTHF — active folate form bypassing MTHFR polymorphism, core component of protocol
- methylcobalamin — active B12 form required as cofactor for methionine synthase in methylation cycle
- SAMe — direct methylation protocol component providing universal methyl donor for all methyltransferases
- homocysteine — primary biomarker for methylation dysfunction; protocol aims <7 µmol/L reduction
- MTHFR — genetic polymorphism (C677T, A1298C) creating methylation bottleneck bypassed by 5-MTHF supplementation
- COMT — catechol-O-methyltransferase genotype (Val158Met) determines protocol dosing strategy and overmethylation risk
- betaine — alternative remethylation pathway substrate via BHMT enzyme, especially important with folate pathway blocks
- BHMT — betaine-homocysteine methyltransferase provides folate-independent remethylation using betaine as methyl donor
- melatonin — provides 3 methyl groups per molecule when metabolized, dual function in protocol (methylation + circadian)
- Epigenetic Modifications — methylation protocol directly modulates histone and DNA methylation controlling gene expression
- EBV — Epstein-Barr virus gene silencing via promoter methylation; protocol suppresses BZLF1 lytic reactivation
- SARS-CoV-2 — viral gene methylation silencing relevant in long COVID viral persistence hypothesis
- long COVID — methylation protocol addresses viral persistence, mitochondrial dysfunction, neuroinflammation in post-acute sequelae
- Depression — protocol supports neurotransmitter synthesis (SAMe → dopamine/serotonin pathways) and reduces inflammatory gene expression
- neurotransmitter — SAMe required for dopamine methylation (PNMT), COMT-mediated catecholamine degradation, phosphatidylcholine synthesis
- detoxification — methylation cycle feeds transsulfuration pathway (homocysteine → cysteine → glutathione) and phase II conjugation
- glutathione — transsulfuration pathway converts excess homocysteine to cysteine for GSH synthesis when methylation adequate
- IL-6 — inflammatory cytokine gene promoter silenced by DNA methylation; protocol reduces transcriptional activity
- TNF-α — tumor necrosis factor alpha gene expression reduced through promoter methylation restoration
- Vitamin B6 — P5P form required for CBS enzyme (homocysteine → cysteine), serine hydroxymethyltransferase, and transsulfuration
- Vitamin B12 — methylcobalamin form serves as cofactor for methionine synthase; deficiency causes homocysteine elevation and methylation failure
- folate — natural form from leafy greens; synthetic folic acid in fortified foods blocks DHFR and competes with 5-MTHF
- choline — precursor to betaine via oxidation; phosphatidylcholine source for acetylcholine synthesis and membrane integrity
- zinc — cofactor for BHMT enzyme in alternative betaine pathway; also required for alcohol dehydrogenase and carbonic anhydrase
- magnesium — required for MAT enzyme (methionine → SAMe) and all ATP-dependent methyltransferases
- NAC — N-acetylcysteine provides cysteine for glutathione synthesis; added when transsulfuration pathway needs support
- histamine — histamine N-methyltransferase (HNMT) requires SAMe for histamine degradation; undermethylation causes histamine intolerance
- estrogen — estrogen metabolism via COMT requires methylation; protocol improves estrogen detoxification and receptor methylation
- autoimmunity — methylation dysfunction allows inflammatory gene overexpression driving autoimmune conditions
- rheumatoid arthritis — promoter hypomethylation of IL-6, TNF-α genes; protocol restores epigenetic silencing
- multiple sclerosis — myelin autoimmunity involves methylation dysregulation; protocol supports immune tolerance via Treg function
- Hashimoto's thyroiditis — thyroid autoimmunity linked to methylation dysfunction; protocol reduces TPO antibody production
- Type 1 Diabetes — beta cell stress and GAD-65 neoantigen formation involves epigenetic dysregulation addressable via methylation
- mitochondrial dysfunction — SAMe required for cardiolipin synthesis (inner mitochondrial membrane); methylation supports ATP production
- chronic inflammation — epigenetic maintenance of inflammatory gene expression reversed by methylation restoration
- chronic fatigue syndrome — methylation dysfunction common in ME/CFS; protocol addresses energy metabolism and viral reactivation
- fibromyalgia — central sensitization involves epigenetic pain gene amplification; methylation modulates nociceptive pathways
- Module 8 (Epigenetics and Evolutionary Medicine — primary module for methylation cycle, SAMe biochemistry, COMT phenotyping, viral gene silencing)